From blank round to a potently active substance?
Saturday, April 20, 2013 - 10:47
in Health & Medicine
A long-forgotten candidate for antiviral therapy is undergoing a renaissance: Since the 1970s, the small molecule CMA has been considered a potent agent against viral infections, yet it was never approved for clinical use. Scientists have now deciphered how the molecule can actually stimulate the immune system to combat viruses.